Although proteins are composed out of only a small number of distinct amino acids, this deceptive simplicity quickly vanishes when considering the many possible sequences across a protein, not to ...

Designing de novo proteins holds immense potential for achieving superior combinations of novel functions and mechanical properties, thereby advancing biological and engineering applications. However, ...

Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...

Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature. The explosion in text-to-image AI models like OpenAI’s DALL-E 2—programs trained to ...

A team of researchers led by Peter Calvert (SUNY Upstate Medical University) has, for the first time, measured the diffusion coefficient of a protein in a primary cilium and in other major ...

The ability to alter protein binding can create tailored therapeutics with reduced side effects, sensitive diagnostic tools, targeted drug delivery and sustainable bioremediation. BIRMINGHAM, Ala. – ...

This is the third in a three-part series from Medscape on the impact of AI on drug discovery and development. Part 1 is about AI's role in designing speedier, more effective clinical trials. Part 2 is ...

Fruit flies, mice, zebrafish, yeast and the tiny worm C. elegans are model organisms that have carried modern biology on ...